We read with great interest the article by Dr Shamsuzzaman and colleagues 1 dealing with the possible relationship between plasma leptin and C-reactive protein (CRP) in healthy humans. The results of their study demonstrated that hyperleptinemia is associated with increased CRP independently of age, body mass index (BMI), waist-tohip ratio, smoking, and alcohol consumption in both men and women. The authors also indicated that, when only subjects with BMI Ͻ25 kg/m 2 were considered, a significant correlation between plasma leptin and CRP was still evident. The authors proposed that both leptin and CRP might be involved in inflammatory and cardiovascular disease processes in normal humans.
Response
We very much appreciate the interest of Drs Tsuda and Nishio in our work. 1 They raise the interesting possibility that leptin contributes importantly to the regulation of nitric oxide production. Evidence about the breadth of actions of leptin is evolving, particularly with regard to the cardiovascular system. Leptin has been found to be relevant to many aspects of cardiac and vascular regulation, including angiogenesis, 2 thrombosis, 3 hemodynamics, 4 and cardiac hypertrophy, among others. Leptin also contributes to the modulation of metabolism, breathing control, 5 and inflammation, all of which may further influence cardiovascular health and disease. It is interesting that leptin's spectrum of actions includes effects that are potentially both beneficial and harmful. Evidence suggests that higher leptin levels are independently related to poorer cardiovascular outcomes. 6 How the range of leptin's actions relates to its prognostic implications remains unclear. Further delineation is needed of the specific actions of leptin, as well its differential effects-for example, in men compared with women, in obese compared with lean individuals, and in health compared with disease. The observations of Tsuda and Nishio about leptin and nitric oxide address, in part, these important questions. We have not analyzed plasma nitric oxide metabolite levels and therefore have no information about these measurements in our study population.
